Does the platelet‑to‑lymphocyte ratio have a prognostic effect in patients with myelodysplastic syndrome?
Autor: | S Akinci, Aysun Şentürk Yıkılmaz, S M Bakanay, I Dilek |
---|---|
Rok vydání: | 2020 |
Předmět: |
Economics and Econometrics
medicine.medical_specialty Lymphocyte Gastroenterology Bone Marrow hemic and lymphatic diseases Internal medicine Materials Chemistry Media Technology Humans Medicine Lymphocyte Count Lymphocytes Grading (tumors) Survival analysis Aged Acute leukemia Cytopenia Leukemia Platelet Count business.industry Myelodysplastic syndromes Forestry Prognosis medicine.disease body regions medicine.anatomical_structure Dysplasia Myelodysplastic Syndromes Bone marrow business |
Zdroj: | Bratislava Medical Journal. 121:422-427 |
ISSN: | 1336-0345 |
DOI: | 10.4149/bll_2020_068 |
Popis: | INTRODUCTION Myelodysplastic syndromes (MDS) include various hematologic abnormalities characterized by chronic cytopenia due to disruption in cellular differentiation. This study aims to evaluate the prognostic value of PLR in patients with MDS. MATERIAL AND METHODS Clinical-laboratory findings and the results of bone marrow biopsies of MDS patients before treatment were recorded. p value of |
Databáze: | OpenAIRE |
Externí odkaz: |